Researchers who often do experiments know that organic synthesis is a process of preparing more complex target molecules from simple raw materials through one or more chemical reactions. Generally, it requires fewer steps, and cheap raw materials. 185629-32-7, name is Methyl 4-amino-3-fluorobenzoate, A new synthetic method of this compound is introduced below., Recommanded Product: Methyl 4-amino-3-fluorobenzoate
Example 38A Methyl 4-{[(6-bromo-3-methyl-2-phenylquinolin-4-yl)carbonyl]amino}-3-fluorobenzoate (0496) (0497) 1.00 g (2.55 mmol) of the compound from example 2A were dissolved in 10 ml of 49 DMF. To the solution were added 474 mg (2.80 mmol) of 158 methyl 4-amino-3-fluorobenzoate and 429 mg (3.82 mmol) of 153 potassium tert-butoxide. The reaction mixture was stirred at RT for 1 h and then stirred into a mixture of 50 ml of 44 ice-water, 50 ml of 159 ammonium chloride solution and 100 ml of 61 ethyl acetate. The organic phase was removed, washed twice with water and once with saturated sodium chloride solution, and dried over magnesium sulfate. The solvent was removed under reduced pressure and the residue was purified by means of column chromatography (silica gel, eluent: 5% ethyl acetate/95% cyclohexane?15% ethyl acetate/85% cyclohexane?45% ethyl acetate/55% 160 cyclohexane, Biotage). The product-containing fractions were concentrated and the residue was stirred in 10 ml of 45 tert-butyl methyl ether. The solids were filtered off, washed twice with 5 ml of tert-butyl methyl ether and then stirred in 4 ml of ethyl acetate for three days. The solids were then filtered off again and dried under reduced pressure. 810 mg (64% of theory, 99% purity) of the 161 title compound were obtained. (0498) 1H-NMR (400 MHz, DMSO-d6): delta [ppm]=11.10 (s, 1H), 8.27 (t, 1H), 8.05 (d, 1H), 7.99 (d, 1H), 7.95-7.90 (m, 2H), 7.85 (dd, 1H), 7.64-7.62 (m, 2H), 7.58-7.51 (m, 3H), 3.89 (s, 3H), 2.43 (s, 3H). (0499) LC/MS (Method 1, ESIpos): Rt=1.27 min, m/z=493/495 [M+H]+.
The synthetic route of 185629-32-7 has been constantly updated, and we look forward to future research findings.
Reference:
Patent; Bayer Pharma Aktiengesekkschaft; BECK, Hartmut; THALER, Tobias; KAST, Raimund; MEIBOM, Daniel; MEININGHAUS, Mark; TERJUNG, Carsten; DELBECK, Martina; LUSTIG, Klemens; MUENSTER, Uwe; OLENIK, Britta; (100 pag.)US2017/260140; (2017); A1;,
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics